Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-07-22
DOI
10.3389/fphar.2015.00147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN
- (2015) Andrew D Beggs et al. Oncotarget
- Targeting ATR in DNA damage response and cancer therapeutics
- (2013) Emmanouil Fokas et al. CANCER TREATMENT REVIEWS
- DNA-dependent Protein Kinase Regulates DNA End Resection in Concert with Mre11-Rad50-Nbs1 (MRN) and Ataxia Telangiectasia-mutated (ATM)
- (2013) Yi Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
- (2013) Maria Gilardini Montani et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase
- (2013) Yunfei Zhou et al. Molecular Oncology
- Epigenetic and genetic features of 24 colon cancer cell lines
- (2013) D Ahmed et al. Oncogenesis
- The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines
- (2012) David Davidson et al. INVESTIGATIONAL NEW DRUGS
- CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy
- (2012) A. Siddiqui-Jain et al. MOLECULAR CANCER THERAPEUTICS
- Visualization of a DNA-PK/PARP1 complex
- (2012) Laura Spagnolo et al. NUCLEIC ACIDS RESEARCH
- ATR signalling: more than meeting at the fork
- (2011) Edward A. Nam et al. BIOCHEMICAL JOURNAL
- Activation of ATR and related PIKKs
- (2011) Daniel A. Mordes et al. CELL CYCLE
- Targeting the S and G2 checkpoint to treat cancer
- (2011) Tao Chen et al. DRUG DISCOVERY TODAY
- Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells
- (2011) David Davidson et al. INVESTIGATIONAL NEW DRUGS
- Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells
- (2011) David Davidson et al. INVESTIGATIONAL NEW DRUGS
- Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy
- (2011) Lilian Amrein et al. LEUKEMIA RESEARCH
- Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
- (2011) Philip M Reaper et al. Nature Chemical Biology
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Common mechanisms of PIKK regulation
- (2009) Courtney A. Lovejoy et al. DNA REPAIR
- Emerging common themes in regulation of PIKKs and PI3Ks
- (2009) Harri Lempiäinen et al. EMBO JOURNAL
- DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
- (2008) E. Willmore et al. CLINICAL CANCER RESEARCH
- Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition
- (2008) Padmini S. Kedar et al. DNA REPAIR
- Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer
- (2008) Thomas D. Penning et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search